Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Candor Rx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Candor Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 163 · Grade C

Candor Rx

Visit Candor Rx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 70 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Candor Rx a bad call — it's best for readers who value an advertised flat-dose model and can confirm the actual medication charge, refill cycle and pharmacy before ordering. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
71
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
76
Track Record
88
65
CoreAge RxBrief Score 94 · 70Candor Rx

Price, coverage & the tracker

CoreAge RxCandor Rx
Brief Score94/100 (A)70/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current price

A $95 headline conflicts with the $99 semaglutide card. Full charge, supply and renewal rate need confirmation.

Full price details

Compounded semaglutide offered; complete current quote unknown because advertised prices conflict; earlier listing: From $99/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm current price

A $95 headline conflicts with the $149 tirzepatide card. Full charge, supply and renewal rate need confirmation.

Full price details

Compounded tirzepatide offered; complete current quote unknown because advertised prices conflict; earlier listing: From $149/mo (all doses, compounded)

CoverageUS only; restrictions by state, confirmed at intakeUS service with state- and medication-specific restrictions; confirm access for your location
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Candor Rx: The live $95 headline conflicts with $99 semaglutide/$149 tirzepatide cards. A complete current quote is unconfirmed, so historical price dates remain unchanged.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.